Page 34 - CIRN Annual Report 2017

through 2013/14 season: A pooled analysis from the Serious Outcomes Surveillance
prevention of influenza-related hospitalization in Canadian seniors over the 2011/12
MacKinnon-Cameron, A McCarthy, JE McElhaney, A McGeer, M Nichols, A Poirier,
Richardson, M Semret, V Shinde, S Smith, D Smyth, G Stiver, G Taylor, S Trottier, L
uenza uenza uenza
MacKinnon-Cameron, A McCarthy, JE McElhaney, A McGeer, A Poirier, J Powis, D
Research Day, April 12,2017. Department of Medicine Research Day, April 12,2017.
Mitoma, G Dos Santos, M ElSherif, K Green, F Haguinet, SA Halperin, B Ibarguchi,
J Powis, D Richardson, M Semret, V Shinde, S Smith, D Smyth, G Stiver, G Taylor,
J Johnstone, K Katz, JM Langley, J LeBlanc, P Lagacé-Wiens, B Light, M Loeb, D
S McNeil, T Hatchette, M Andrew, A Ambrose, G Boivin, W Bowie, A Chit4, F Diaz-
Valiquette, D Webster, SA McNeil on behalf of the Serious Outcomes Surveillance
Chit, G Dos Santos, M ElSherif, K Green, F Haguinet, SA Halperin, B Ibarguchi, J
among patients with chronic obstructive pulmonary disease (COPD) admitted to
Johnstone, K Katz, JM Langley, J LeBlanc, P Lagacé-Wiens, B Light, M Loeb, D
S Mulpuru, L Li, L Ye, T Hatchette, M Andrew, A Ambrose, G Boivin, W Bowie, A
S Trottier, L Valiquette, D Webster, L Ye on behalf of the Canadian Immunization
the Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators. Vaccine
vaccines (TIV) in the prevention of influenza-related hospitalization in Canadian
(SOS) Network of the Canadian Immunization Research Network (CIRN). DOM
Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network and
Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization
seniors over the 2011/12 through 2013/14 season: A pooled analysis from the
effectiveness (VE) of non-adjuvanted and adjuvanted trivalent inactivated infl
Research Network (CIRN). Infectious Diseases Research Day, April 11, 2017.
(SOS) Network of the Canadian Immunization Research Network (CIRN). Infl
burden, risk factors for severe disease and influenza vaccine effectiveness
rmed influenza: A study from the Serious Outcomes Surveillance (SOS) network of the Canadian Immunization Research Network (CIRN). Hatchette, B Ibarguchi, J Johnstone, K Katz, JM Langley, J LeBlanc, P Lagacé-Wiens, Surveillance (SOS) network of the Canadian Immunization Research Network (CIRN).
Z Shaffelburg, L Ye, M Nichols, M Andrew, A Ambrose, G Boivin, W Bowie, A Chit, F Diaz-Mitoma, G Dos Santos, M ElSherif, K Green, F Haguinet, SA Halperin, T B Light, M Loeb, D MacKinnon-Cameron, A McCarthy, JE McElhaney, A McGeer, A Poirier, J Powis, D Richardson, M Semret, V Shinde, S Smith, D Smyth, G Stiver, G Taylor, S Trottier, L Valiquette, D Webster, and SA McNeil on behalf of the Canadian
Infectious Diseases Research Day, April 11, 2017. Halifax, NS. Infectious Diseases Research Day, April 11, 2017. Halifax, NS.
hospital with laboratory-confi

Halifax, NS. Halifax, NS.

uenza vaccine uenza-related hospitalization

SA McNeil. Preliminary end-of-season estimates of 2014/15 infl

rmed infl from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network. Infectious Diseases Society of America, October M Hux, L Ye, R Goeree, E Thommes, S Noorduyn, SA McNeil. Canadian cost of lab- rmed influenza requiring hospitalization. Canadian Association for Population S McNeil, T Hatchette, M Andrew, A Ambrose, G Boivin, F Diaz-Mitoma, W Bowie, A Chit, G Dos Santos, M ElSherif, K Green, F Haguinet, SA Halperin, B Ibarg

effectiveness in preventing laboratory-confi 7-11, 2015. San Diego, California. confi Therapeutics, November 1-3, 2015. Toronto, Ontario. Medicine Research Day, April 12,2017. Halifax, NS. confi NS. 32